FoxM1 is aberrantly high-expressed in almost all solid cancers in our data analysis, like bladder cancer, breast cancer, sarcoma, colorectal cancer and lung cancer (Fig. 1a). Here, FOXM1 is linked to urinary bladder carcinoma.